PRKCD and breast carcinoma: More recently, Martens et al (2005) reported that hypermethylation of the PKCδ gene in oestrogen receptor (ER)-positive breast cancer patients was associated with a favourable response to hormone therapy in patients with advanced breast cancer, whereas Assender et al (2007) found that elevated PKCδ protein was associated with endocrine sensitivity.